Patent US5366990A successfully refreshed from Google Patents.
US5366990A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for treating alcohol abuse and alcoholism
Assignee: Individual
•
Filing: 1991-11-14
•
Granted: 1994-11-22
•
Expires: 2011-11-14
Abstract
Abstract A method for decreasing appetite for alcohol in humans which comprises the steps of providing an effective dosage of an alpha-2-adrenergic antagonist to the subject.
Inventors
- 👤 Larry D. Reid
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 15:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
20 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of methoxyidazoxan.
Claim 2
Independent Claim
20 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of methoxyidazoxan.
Claim 3
Dependent Claim
12 words
The method of claim 1 wherein said effective dosage is administered orally.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein said effective dosage is administered by subcutaneous injection.
Claim 5
Dependent Claim
14 words
The method of claim 1 wherein said effective dosage is administered by intramuscular injection.
Claim 6
Independent Claim
20 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of RS-21361.
Claim 7
Independent Claim
20 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of RS-21361.
Claim 8
Dependent Claim
12 words
The method of claim 5 wherein said effective dosage is administered orally.
Claim 9
Dependent Claim
14 words
The method of claim 5 wherein said effective dosage is administered by subcutaneous injection.
Claim 10
Dependent Claim
14 words
The method of claim 5 wherein said effective dosage is administered by intramuscular injection.
Claim 11
Independent Claim
31 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of an alpha-2-adrenergic antagonist selected from the group consisting of RS-49640 and RS-84663.
Claim 12
Independent Claim
31 words
A method for decreasing appetite for alcohol in humans which comprises administering to said humans an effective dosage of an alpha-2-adrenergic antagonist selected from the group consisting of RS-49640 and RS-84663.
Claim 13
Dependent Claim
12 words
The method of claim 9 wherein said effective dosage is administered orally.
Claim 14
Dependent Claim
14 words
The method of claim 9 wherein said effective dosage is administered by subcutaneous injection.
Claim 15
Dependent Claim
14 words
The method of claim 9 wherein said effective dosage is administered by intramuscular injection.
References Cited (Backward Citations)
US4144348A
Cited
US4133348A
Cited
US4761429A
Cited
US4931277A
Cited
US4808574A
Cited
US4895848A
Cited
US4983632A
Cited
US4968692A
Cited
US5109007A
Cited
US5013752A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-11-21 | 1998-05-23 | 1998-11-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-11-21 | 2002-05-23 | 2002-11-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-11-21 | 2006-05-23 | 2006-11-22 | $7700.00 | Window Closed / Lapsed |